VanEck Pharmaceutical ETF (PPH) Dividend Yield, History & Forecast

VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund (ETF) listed on the NASDAQ Global Market. The most recent ex-dividend date was April 1, 2026, with payment scheduled for April 7, 2026. market capitalization is approximately $615M.

Frequently Asked Questions about VanEck Pharmaceutical ETF (PPH)

When does VanEck Pharmaceutical ETF pay distributions?
The most recent ex-dividend date was April 1, 2026. The next scheduled dividend payment date is April 7, 2026.
How many years has VanEck Pharmaceutical ETF increased its dividend?
VanEck Pharmaceutical ETF (PPH) has increased its dividend for 3 consecutive years.
What does VanEck Pharmaceutical ETF invest in?
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.